BridgeBio Pharma, Inc. (BBIO) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bridgebio Pharma, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.031 We'll 00:00:13.750 -- 00:00:18.734 be going live in five, four, three. 00:00:20.580 -- 00:00:23.925 Good afternoon. I'll be your conference operator today. 00:00:23.925 -- 00:00:27.976 All lines have been placed on mute to prevent any background noise. 00:00:27.976 -- 00:00:32.182 After the company's remarks, there will be a question and answer session. 00:00:32.182 -- 00:00:36.848 If you would like to ask a question, press star followed by the number one on your telephone 00:00:36.848 -- 00:00:41.835 keypad. If you would like to withdraw your question, press the pound key. 00:00:41.835 -- 00:00:46.602 Thank you. Before we begin, I'd like to remind everyone that today's call may contain 00:00:46.602 -- 00:00:51.689 forward-looking statements within the meaning of the federal securities laws, including 00:00:51.689 -- 00:00:57.592 but not limited to statements about BridgeBio's future operating and financial performance. 00:00:57.592 -- 00:01:01.496 business plans, and prospects, and strategy. 00:01:01.496 -- 00:01:05.720 These statements are based on current expectations and assumptions that are subject to 00:01:05.720 -- 00:01:11.125 risks and uncertainties, which could cause actual results to differ materially 00:01:11.125 -- 00:01:15.429 from those expressed or implied in these forward-looking statements. 00:01:15.429 -- 00:01:19.854 For a discussion of these risks and uncertainties, please refer to the disclosure in 00:01:19.854 -- 00:01:24.811 today's earnings release and BridgeBio's periodic reports and SEC filings. 00:01:24.811 -- 00:01:29.981 All statements made here are based on information available to Bridge Bio as of today, 00:01:29.981 -- 00:01:34.689 and the company undertakes no obligation to update any forward-looki...